Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · May 18, 2023

Fracture Risk Reduction With and Safety of Osteoporosis Treatment Compared With Placebo or an Active Comparator in Postmenopausal Women

BMJ : British Medical Journal


Additional Info

Disclosure statements are available on the authors' profiles:

BMJ : British Medical Journal
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials
BMJ 2023 May 02;381(xx)e068033, MN Händel, I Cardoso, C von Bülow, JF Rohde, A Ussing, SM Nielsen, R Christensen, JJ Body, ML Brandi, A Diez-Perez, P Hadji, MK Javaid, WF Lems, X Nogues, C Roux, S Minisola, A Kurth, T Thomas, D Prieto-Alhambra, SL Ferrari, B Langdahl, B Abrahamsen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading